SAS-B approvals dip in February by Steve Jones March 9, 2026March 9, 2026 Approvals through the Special Access Scheme fell marginally in February although the 2026 two-month total remains […]
Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026
SAS-B deep dive: approvals climb 26% in 2025 as flower overtakes oil and pastilles surge by Adam Sheldon January 13, 2026January 14, 2026
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
‘Houston, we have a bit of a problem’: Chief TGA medical adviser flags systemic issues across sector by Adam Sheldon November 18, 2025February 21, 2026
TGA reviewing 751 submissions as industry outlines roadmap for reform by Adam Sheldon October 8, 2025October 8, 2025
Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025
SAS-B approvals slow in August but pastille scripts continue to rise by Steve Jones September 3, 2025February 21, 2026
